Spruce Biosciences Ownership | Who Owns Spruce Biosciences?
Spruce Biosciences Ownership Summary
Spruce Biosciences is owned by 96.50% institutional investors, 3.51% insiders. Ikarian capital is the largest institutional shareholder, holding 15.83% of SPRB shares. Vanguard Total Stock Mkt Idx Inv is the top mutual fund, with 2.82% of its assets in Spruce Biosciences shares.
SPRB Ownership Benchmark
| Type | Name | % Inst | % Insiders | % Retail |
|---|---|---|---|---|
| Stock | Spruce Biosciences | 96.50% | 3.51% | -0.01% |
| Sector | Healthcare Stocks | 35.42% | 11.83% | 52.76% |
| Industry | Biotech Stocks | 35.46% | 11.78% | 52.76% |
Institutional Shareholders
Top Institutional Shareholders by Total Shares
| Holder | Shares | % Holding | Value |
|---|---|---|---|
| Ikarian capital | 121.36K | 15.83% | $7.93M |
| Millennium management | 111.89K | 14.60% | $7.31M |
| Citadel advisors | 70.00K | 9.13% | $4.57M |
| Rivervest venture management | 2.94M | 7.14% | $1.52M |
| Alyeska investment group | 51.67K | 6.74% | $3.38M |
| Wellington management group llp | 48.80K | 6.37% | $3.19M |
| Rock springs capital management lp | 2.61M | 6.32% | $1.10M |
| Boothbay fund management | 42.08K | 5.49% | $2.75M |
| Balyasny asset management | 40.00K | 5.22% | $2.61M |
| Carlyle group | 38.62K | 5.04% | $2.52M |
Top Institutional Shareholders by % of Total Assets
| Holder | Shares | % Assets | Value |
|---|---|---|---|
| Rivervest venture management | 2.94M | 22.27% | $1.52M |
| Ikarian capital | 121.36K | 0.64% | $7.93M |
| Lion point capital, lp | 1.00K | 0.39% | $65.35K |
| Resolute capital asset partners | 4.00K | 0.14% | $261.40K |
| Diadema partners lp | 10.00K | 0.11% | $653.50K |
| Quinn opportunity partners | 26.81K | 0.09% | $1.75M |
| Stempoint capital lp | 6.36K | 0.08% | $415.63K |
| Persistent asset partners | 2.53K | 0.06% | $165.21K |
| Rock springs capital management lp | 2.61M | 0.04% | $1.10M |
| Boothbay fund management | 42.08K | 0.04% | $2.75M |
Top Buyers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Millennium management | 111.89K | 0.00% | 111.89K |
| Susquehanna group, llp | 58.98K | - | 58.98K |
| Diadema partners lp | 10.00K | 0.11% | 10.00K |
| Stempoint capital lp | 6.36K | 0.08% | 6.36K |
| Vanguard fiduciary trust | 5.51K | 0.00% | 5.51K |
Top Sellers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Rosalind advisors | - | - | -1.51M |
| Aisling capital management lp | - | - | -1.21M |
| Acadian asset management | - | - | -1.05M |
| Vanguard group | - | - | -843.84K |
| Altium capital management lp | - | - | -811.17K |
New Positions
| Holder | Shares | % Assets | Change | Value |
|---|---|---|---|---|
| Millennium management | 111.89K | 0.00% | 111.89K | $7.31M |
| Susquehanna group, llp | 58.98K | - | 58.98K | $24.77K |
| Diadema partners lp | 10.00K | 0.11% | 10.00K | $653.50K |
| Stempoint capital lp | 6.36K | 0.08% | 6.36K | $415.63K |
| Vanguard fiduciary trust | 5.51K | 0.00% | 5.51K | $360.34K |
Sold Out
| Holder | Change |
|---|---|
| Qube research | -2.00 |
| Royal bank of canada | -40.00 |
| Jpmorgan chase | -65.00 |
| Fmr | -103.00 |
| Wells fargo & company/mn | -143.00 |
Institutional Ownership Trends
| Date | Holdings | Change % | Shares | Change % | Ownership | Change % | Increased Position | Change % | Decreased Position | Change % |
|---|---|---|---|---|---|---|---|---|---|---|
| Mar 31, 2026 | 32 | - | 739,765 | -1.87% | 96 | 0.54% | 16 | -44.83% | 6 | 500.00% |
| Dec 31, 2025 | 32 | 255.56% | 753,855 | -74.34% | 133 | 0.05% | 29 | 314.29% | 1 | -50.00% |
| Sep 30, 2025 | 9 | 200.00% | 2,937,895 | 43.53% | 521 | 2575.15% | 7 | - | 2 | - |
| Jun 30, 2025 | 3 | -89.29% | 2,046,828 | -73.79% | 4 | 1.51% | - | -100.00% | - | -100.00% |
| Mar 31, 2025 | 30 | - | 10,436,800 | -6.52% | 23 | 3.25% | 10 | -9.09% | 7 | -30.00% |
Top Mutual Funds Shareholders
| Holder | Shares | % Holding | Change |
|---|---|---|---|
| Vanguard Total Stock Mkt Idx Inv | 76.23K | 2.82% | 69.92K |
| Vanguard US Total Market Shares ETF | 638.56K | 1.55% | - |
| Vanguard Institutional Extnd Mkt Idx Tr | 11.91K | 0.44% | - |
| Wellington CIF Small Cap 2000 | 4.11K | 0.30% | 2.55K |
| Extended Equity Market Fund E | 3.48K | 0.25% | 3.48K |
| Extended Equity Market Fund B | 3.48K | 0.25% | 3.48K |
| Fidelity Extended Market Index | 5.99K | 0.22% | 306.00 |
| Extended Equity Market Fund K | 2.96K | 0.22% | -22.00 |
| Wellington CIF Biotechnology | 2.40K | 0.18% | 2.40K |
| Blackrock Extended Mkt Fund CF | 3.48K | 0.13% | - |
Recent Insider Transactions
| Date | Name | Role | Activity | Value |
|---|---|---|---|---|
| Oct 06, 2025 | Parkman Healthcare Partners LLC | - | Buy | $4.59K |
| Oct 06, 2025 | Parkman Healthcare Partners LLC | - | Sell | $436.39 |
| Oct 06, 2025 | Parkman Healthcare Partners LLC | - | Sell | $4.48K |
| Mar 21, 2024 | Novo Holdings A/S | - | Sell | $350.95K |
| Mar 19, 2024 | Novo Holdings A/S | - | Sell | $447.71K |
Insider Transactions Trends
| Date | Buy | Sell |
|---|---|---|
| 2026 Q1 | - | - |
| 2025 Q4 | 1 | 2 |
| 2025 Q3 | - | - |
| 2024 Q4 | - | - |
| 2024 Q2 | - | - |
SPRB Ownership FAQ
Try Tickergate Pro Free
Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)
Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis
Discover trending investment themes
Find your next best investment
Research stocks using tools